Adam Berger

Adam C. Berger, Ph.D. is a Senior Program Officer and Director of the Roundtable on Translating Genomic-Based Research for Health in the Board on Health Sciences Policy at the Institute of Medicine (IOM). His primary interests focus on policy issues relating to translational medicine, including the development of drug, diagnostic, and clinical and public health applications. In his capacity at the IOM, Dr. Berger has facilitated public workshops and resulting reports such as Genome-Based Diagnostics: Clarifying a Pathway to Clinical Use; Integrating Large-Scale Genomic Information into Clinical Practice; Genome-Based Therapeutics: Targeted Drug Discovery and Development; and The Value of Genetic and Genomic Technologies. Dr. Berger received his doctorate from Emory University in the Biochemistry, Cell and Developmental Biology Program, his B.S. in Molecular Genetics from The Ohio State University, and completed his postdoctoral training at the National Cancer Institute of the National Institutes of Health (NIH). He is the recipient of the NIH Fellows Award for Research Excellence and a Ruth L. Kirschstein National Research Service Award.